Your session is about to expire
← Back to Search
Low-Fructose Diet for Fatty Liver Disease in Youth (FLY Trial)
FLY Trial Summary
This trial will compare how two different diets (high vs low in high fructose corn syrup or HFCS) may affect how much fat gets deposited in the liver and whether or not a lower diet in HFCS can help decrease liver damage in adolescents with non-alcoholic fatty liver disease (NAFLD).
FLY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FLY Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have Type 2 Diabetes or I am on insulin.I have a liver condition related to fat buildup, like fatty liver disease.I am currently in a weight loss program or have had bariatric surgery.I am taking medication that can affect my liver, like methotrexate or steroids.My child cannot participate in study procedures due to a significant developmental delay or other major health issue.I am not pregnant and can take a pregnancy test before the MRI.I am an obese teenager with a diagnosed liver condition.
- Group 1: Intervention group
- Group 2: Control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have been accepted in to this research project?
"Affirmative. According to clinicaltrials.gov, this experiment commenced recruitment on April 30th 2015 and is still actively recruiting participants; the most recent version was updated on September 2nd 2022. The research needs 70 people from a single facility."
Could I potentially qualify to take part in this exploration?
"This research project is enrolling 70 individuals between 12 and 18 years old, who have been clinically diagnosed with nonalcoholic steatohepatitis. Furthermore, candidates must be classified as obese through the Tanner Stage III-V criteria."
Does this research encompass individuals aged thirty and above?
"In order to be considered for this trial, participants must fit the age criteria of 12-18 years. 33 trials are available specifically for those under 18 while 319 have been constructed with individuals above 65 in mind."
Is enrollment for this investigative trial open at present?
"This clinical trial is currently seeking to enroll participants. The initial posting of the study was on April 30th 2015 and it has been most recently updated as of September 2nd 2022, according to data hosted by clinicaltrials.gov."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger